author-photo

R. Bonanthaya

Kidwai Memorial Institute of Oncology

3

Papers

100

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients

2014 Oral Oncology
Show All
- Source
- Cite
- Save
Citations (71)
An open-label, randomized, study of h-R3mAb (nimotuzumab) in patients with advanced (stage III or IVa) squamous cell carcinoma of head and neck (SCCHN): Four-year survival results from a phase IIb study.

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (29)
P89 Feasibility, cosmetic outcome, and Quality of Life of patients receiving two different radiotherapy boost techniques for breast conservation:An Indian experience

2007 The Breast
Show All
- Source
- Cite
- Save
Citations (0)